FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Galderma Laboratories, L.P. Doxycycline Recall

Doxycycline, USP Capsules 40 mg, Packaged in 30 ct Bottles, Rx Only

Galderma Laboratories, L.P. · Fort Worth, TX

Risk level
Class III
Reported by FDA
Jun 22, 2016
Recall ID
D-1031-2016
Check your lot numberHow we source this data

Summary

Galderma Laboratories, L.P. recalled Doxycycline starting May 19, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1031-2016 on Jun 22, 2016. Reason: Labeling: Incorrect Or Missing Lot and/or Exp Date: Some expiries and lot numbers are missing. Status: Terminated.

Why it was recalled

Labeling: Incorrect Or Missing Lot and/or Exp Date: Some expiries and lot numbers are missing.

Product description

Doxycycline, USP Capsules 40 mg, Packaged in 30 ct Bottles, Rx Only. Marketed by: Prasco Laboratories, Mason, OH 45040 USA, Manufactured by: Catalent Pharma Solutions, LLC, Winchester, Kentucky 40391. NDC: 66993-815-30.

Lot numbers, UPCs & expiration codes

Lot #: 1496059A, Expiry: 08/31/2017; Lot #: AD9848A, Expiry: 11/30/2017

Where it was sold

U.S. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1031-2016
Classification
Class III
Status
Terminated
Recall initiated
May 19, 2016
FDA report date
Jun 22, 2016
Quantity
71,340 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Galderma Laboratories, L.P.

Original FDA data

Every field from FDA enforcement report D-1031-2016, exactly as published.

Show all FDA fields
City
Fort Worth
State
TX
Status
Terminated
Country
United States
Event ID
74209
Address
14501 N Freeway Tx
Code information
Lot #: 1496059A, Expiry: 08/31/2017; Lot #: AD9848A, Expiry: 11/30/2017
Postal code
76177
Report date
Jun 22, 2016
Product type
Drugs
Recall number
D-1031-2016
Classification
Class III
Recalling firm
Galderma Laboratories, L.P.
Product quantity
71,340 Bottles
Termination date
Dec 23, 2016
Reason for recall
Labeling: Incorrect Or Missing Lot and/or Exp Date: Some expiries and lot numbers are missing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Doxycycline, USP Capsules 40 mg, Packaged in 30 ct Bottles, Rx Only. Marketed by: Prasco Laboratories, Mason, OH 45040 USA, Manufactured by: Catalent Pharma Solutions, LLC, Winchester, Kentucky 40391. NDC: 66993-815-30.
Distribution pattern
U.S. Nationwide
Recall initiation date
May 19, 2016
Initial firm notification
Letter
Center classification date
Jun 14, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1031-2016, published Jun 22, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls